(S1 (S (NP (NP (NN Absence)) (PP (IN of) (NP (NN IRF-4) (NN expression))) (PP (IN in) (NP (NN leukemia) (NNS cells)))) (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NN promoter) (NNS alterations)))))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN demonstrated) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (PP (IN in) (NP (NN leukemia) (NNS patients))) (CC and) (ADVP (RB specifically)) (PP (IN in) (NP (NP (NN CML) (NNS T-cells)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN IRF-4) (NN expression))) (PP (PP (IN in) (NP (NP (JJ various) (JJ hematopoietic) (NN cell) (NNS lines)) (, ,) (ADJP (JJ such) (PP (IN as) (NP (NP (NP (NN Jurkat)) (, ,) (NP (DT a) (NN T-cell) (NN leukemia)) (, ,) (NP (NN CML-T1)) (, ,) (NP (DT a) (JJ bcr-abl-positive) (NN T-cell) (NN line)) (, ,) (NP (NN K-562)) (, ,) (NP (DT a) (JJ bcr-abl-positve) (NN erythroleukemia)) (, ,) (NP (NN U-937)) (, ,) (NP (DT a) (JJ monocytic) (NN leukemia)) (, ,) (NP (NN EM-2)) (CC and) (NP (CD LAMA-84))) (, ,) (NP (JJ bcr-abl-positve) (JJ myeloid) (NN leukemia))))) (, ,))) (CC but) (PP (RB not) (IN in) (NP (NP (NN SD-1)) (, ,) (NP (NP (DT a) (JJ bcr-abl-positive) (JJ acute) (JJ lymphoblastic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN pre) (NN B-ALL)) (-RRB- -RRB-))) (, ,) (NP (CD RPMI-8226)) (, ,) (NP (DT a) (JJ multiple) (NN myeloma)) (CC and) (NP (NP (NN BV-173)) (, ,) (NP (DT a) (JJ bcr-abl-positive) (NN B-cell) (NN line)))))) (-LRB- -LRB-) (PP (FW Figures) (NP (NP (NN 1A)) (CC and) (NP (CD 5D) (-RRB- -RRB-)))))) (. .)))
(S1 (S (S (PP (IN After) (NP (NP (NN sequencing)) (PP (IN of) (NP (DT the) (NN IRF-4) (NN promoter))))) (, ,) (NP (PRP it)) (VP (MD could) (VP (VB be) (VP (VBN excluded) (SBAR (IN that) (S (NP (NP (NN absence)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ above) (NN cell) (NNS lines)))))))) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (JJ genetic) (NNS aberrations))))))))))) (. .)))
(S1 (S (ADVP (RB However)) (, ,) (NP (NP (CD 2) (NN bp) (NNS changes)) (PRN (-LRB- -LRB-) (NP (NP (NN nucleotide) (NN -1081)) (, ,) (NP (NN T) (TO to) (NN C)) (CC and) (NP (NN -1068))) (, ,) (NP (DT A) (TO to) (NN C)) (-RRB- -RRB-))) (VP (MD could) (VP (VB be) (VP (VBN detected) (PP (IN in) (NP (CC both) (NP (DT the) (JJ IRF-4-positive) (NN BV-173)) (CC and) (NP (NP (DT the) (JJ IRF-4-negative) (NN LAMA-84)) (, ,) (NP (NP (NP (NN EM-2)) (CC and) (NP (NN K-562))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (S (PP (IN At) (NP (NN position) (CD -116))) (NP (DT an) (NN A) (TO to) (NN C) (NN substitution)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NN EM-2)) (, ,) (NP (NN K-562)) (CC and) (NP (NN CML-T1))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN Jurkat)) (, ,) (NP (NN BV-173)) (CC and) (NP (NN SD-1))) (VP (VBD exhibited) (NP (NP (DT a) (JJ mixed) (NN A/C) (NN sequence)) (CC and) (NP (NP (NP (NN U-937)) (, ,) (NP (NN LAMA-84)) (CC and) (NP (NP (CD RPMI-8226) (NN no) (NN substitution)) (PP (IN at) (NP (NN all))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (DT these) (NNS alterations)) (VP (VBP are) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB affect) (NP (NN IRF-4) (NN expression)))))))) (. .)))
